Evidence map›Paper›PMID 20053580›Full record

ReviewCurrent opinion in microbiology2010

Anaplasma phagocytophilum and Ehrlichia chaffeensis type IV secretion and Ank proteins.

Yasuko Rikihisa, Mingqun Lin

Abstract readReview
In one paragraph

Review in Current opinion in microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 100 citations in OpenAlex.

  1. Adaptation ofmSphere · 2026
    Article
  2. Article
  3. mBio · 2026
    Article
  4. crANKing up the infection: ankyrin domains inInfection and immunity · 2024
    Review
  5. Article
  6. Three feminizingFrontiers in microbiology · 2024
    Article
  7. mSphere · 2023
    Article
  8. bioRxiv : the preprint server for biology · 2023
    Article
  9. Metagenome diversity illuminates origins of pathogen effectors.bioRxiv : the preprint server for biology · 2023
    Article
  10. Article
  11. RevisitingMicroorganisms · 2021
    Article
  12. Review
  13. Article
  14. SHP-1 suppresses the antiviral innate immune response by targeting TRAF3.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yasuko RikihisaDepartment of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA. rikihisa.1@osu.edu
Mingqun Lin
The Ohio State University · US

Funding

TYPE IV SECRETION &SIGNAL TRANSDUCTION IN EHRLICHIOSISR01AI054476 · NIAID · OHIO STATE UNIVERSITY · PI RIKIHISA, YASUKO · 2004 to 2013
$3.8M
EHRLICHIACIDAL MECHANISM IN MACROPHAGESR01AI030010 · NIAID · OHIO STATE UNIVERSITY · PI RIKIHISA, YASUKO · 1990 to 2009
$2.4M
NIAID NIH HHS R01 AI030010NIAID NIH HHS R01 AI054476NIAID NIH HHS R01 AI30010
6 · The paper itself

Abstract

The obligatory intracellular bacterial pathogens Anaplasma and Ehrlichia infect leukocytes by hijacking host-cell components and processes. The type IV secretion system is up-regulated during infection. Among type IV secretion candidate substrates, an ankyrin repeat protein of Anaplasma phagocytophilum, AnkA, is delivered into the host cytoplasm via a complex that includes VirD4. AnkA is highly tyrosine phosphorylated and binds to the Abl interactor 1, SHP-1, and nuclear DNA fragments. Ehrlichia chaffeensis AnkA was recently reported to be translocated into host-cell nucleus. The recent discovery of several ankyrin repeat proteins secreted via the type IV secretion system of different intracellular bacteria suggests that a common strategy evolved to subvert host-cell functions.

Indexed as

Anaplasma phagocytophilumAnimalsAntigens, BacterialBacterial ProteinsCell NucleusCytoplasmEhrlichia chaffeensisEukaryotic CellsGene Expression RegulationHumansMembrane Transport ProteinsVirulence Factorsank protein, EhrlichiaAntigens, BacterialBacterial ProteinsMembrane Transport ProteinsVirulence Factors

Identifiers

PMID20053580
PMCPMC3251840
OpenAlexW2022069644

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.